Prognostic value of myocardial damage markers in patients with chronic heart failure with atrial fibrillation

Internal Medicine

Volumn 53, Issue 7, 2014, Pages 661-668

  Otaki, Yoichiro ^a   Arimoto, Takanori ^a   Takahashi, Hiroki ^a   Kadowaki, Shinpei ^a   Ishigaki, Daisuke ^a   Narumi, Taro ^a   Honda, Yuki ^a   Iwayama, Tadateru ^a   Nishiyama, Satoshi ^a   Shishido, Tetsuro ^a   Miyashita, Takehiko ^a   Miyamoto, Takuya ^a   Watanabe, Tetsu ^a   Kubota, Isao ^a  

^a YAMAGATA UNIVERSITY   (Japan)

Author keywords

Atrial fibrillation; Heart type fatty acid binding protein; Troponin T

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; EPIDERMAL GROWTH FACTOR RECEPTOR; FATTY ACID BINDING PROTEIN; RADIOISOTOPE; TROPONIN T; WARFARIN; BIOLOGICAL MARKER; FABP3 PROTEIN, HUMAN;

AGED; ARTICLE; BLOOD SAMPLING; DIAGNOSTIC TEST ACCURACY STUDY; ECHOCARDIOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART CATHETERIZATION; HEART FAILURE; HEART MUSCLE INJURY; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; PHYSICAL EXAMINATION; PROGNOSIS; RADIOIMMUNOASSAY; RECEIVER OPERATING CHARACTERISTIC; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SINUS RHYTHM; THORAX RADIOGRAPHY; ATRIAL FIBRILLATION; BLOOD; CARDIOMYOPATHIES; COMPLICATION; HEART MUSCLE; METABOLISM; PATHOPHYSIOLOGY; RETROSPECTIVE STUDY;

AGED; ATRIAL FIBRILLATION; BIOLOGICAL MARKERS; CARDIOMYOPATHIES; FATTY ACID-BINDING PROTEINS; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; MALE; MYOCARDIUM; PROGNOSIS; RETROSPECTIVE STUDIES; TROPONIN T;

EID: 84897428174     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.53.1293     Document Type: Article

References (26)

1. Olsson LG, Swedberg K, Ducharme A, et al. Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction: results from the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) program. J Am Coll Cardiol 47: 1997-2004, 2006.
2. Zakeri R, Chamberlain AM, Roger VL, et al. Temporal relationship and prognostic significance of atrial fibrillation in heart failure patients with preserved ejection fraction: a community-based study. Circulation 128: 1085-1093, 2013.
3. Schotten U, Ausma J, Stellbrink C, et al. Cellular mechanisms of depressed atrial contractility in patients with chronic atrial fibrillation. Circulation 103: 691-698, 2001.
4. Krahn AD, Manfreda J, Tate RB, Mathewson FA, Cuddy TE. The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study. Am J Med 98: 476-484, 1995.
5. Tsang TS, Gersh BJ, Appleton CP, et al. Left ventricular diastolic dysfunction as a predictor of the first diagnosed nonvalvular atrial fibrillation in 840 elderly men and women. J Am Coll Cardiol 40: 1636-1644, 2002.
6. Sanders P, Morton JB, Davidson NC, et al. Electrical remodeling of the atria in congestive heart failure: electrophysiological and electroanatomic mapping in humans. Circulation 108: 1461-1468, 2003.
7. Cha YM, Redfield MM, Shen WK, Gersh BJ. Atrial fibrillation and ventricular dysfunction: a vicious electromechanical cycle. Circulation 109: 2839-2843, 2004.
8. Kostin S, Pool L, Elsasser A, et al. Myocytes die by multiple mechanisms in failing human hearts. Circ Res 92: 715-724, 2003.
9. Olivetti G, Abbi R, Quaini F, et al. Apoptosis in the failing human heart. N Engl J Med 336: 1131-1141, 1997.
10. Fuster V, Ryden LE, Cannom DS, et al. 2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation 123: e269-e367, 2011.
11. Niizeki T, Takeishi Y, Arimoto T, et al. Heart-type fatty acidbinding protein is more sensitive than troponin T to detect the ongoing myocardial damage in chronic heart failure patients. J Card Fail 13: 120-127, 2007.
12. Arimoto T, Takeishi Y, Niizeki T, et al. Cardiac sympathetic denervation and ongoing myocardial damage for prognosis in early stages of heart failure. J Card Fail 13: 34-41, 2007.
13. Giannitsis E, Kurz K, Hallermayer K, Jarausch J, Jaffe AS, Katus HA. Analytical validation of a high-sensitivity cardiac troponin T assay. Clin Chem 56: 254-261, 2010.
14. Kawai M, Yoshimura M, Harada M, et al. Determination of the Btype natriuretic peptide level as a criterion for abnormalities in Japanese individuals in routine clinical practice: the J-ABS Multi-Center Study (Japan Abnormal BNP Standard). Intern Med 52: 171-177, 2013.
15. Trappe K, Thomas D, Bikou O, et al. Suppression of persistent atrial fibrillation by genetic knockdown of caspase 3: a preclinical pilot study. Eur Heart J 34: 147-157, 2013.
16. Bauer A, McDonald AD, Donahue JK. Pathophysiological findings in a model of persistent atrial fibrillation and severe congestive heart failure. Cardiovasc Res 61: 764-770, 2004.
17. Chiu YT, Chen YT, Lin NN, et al. Sympathetic activity and myocardial damage after stimulation of dorsal medulla and vagotomy in a novel animal model. Int J Cardiol 100: 401-407, 2005.
18. Arimoto T, Tada H, Igarashi M, et al. High washout rate of iodine-123-metaiodobenzylguanidine imaging predicts the outcome of catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol 22: 1297-1304, 2011.
19. Osmancik P, Peroutka Z, Budera P, et al. Decreased apoptosis following successful ablation of atrial fibrillation. Cardiology 116: 302-307, 2010.
20. Arimoto T, Takeishi Y, Shiga R, et al. Prognostic value of elevated circulating heart-type fatty acid binding protein in patients with congestive heart failure. J Card Fail 11: 56-60, 2005.
21. Kusumoto A, Miyata M, Kubozono T, et al. Highly sensitive cardiac troponin T in heart failure: comparison with echocardiographic parameters and natriuretic peptides. J Cardiol 59: 202-208, 2012.
22. Viswanathan K, Kilcullen N, Morrell C, et al. Heart-type fatty acid-binding protein predicts long-term mortality and re-infarction in consecutive patients with suspected acute coronary syndrome who are troponin-negative. J Am Coll Cardiol 55: 2590-2598, 2010.
23. Kutsuzawa D, Arimoto T, Watanabe T, et al. Ongoing myocardial damage in patients with heart failure and preserved ejection fraction. J Cardiol 60: 454-461, 2012.
24. Daidoji H, Arimoto T, Nitobe J, et al. Circulating heart-type fatty acid binding protein levels predict the occurrence of appropriate shocks and cardiac death in patients with implantable cardioverterdefibrillators. J Card Fail 18: 556-563, 2012.
25. Sato Y, Fujiwara H, Takatsu Y. Cardiac troponin and heart failure in the era of high-sensitivity assays. J Cardiol 60: 160-167, 2012.
26. Meng X, Ming M, Wang E. Heart fatty acid binding protein as a marker for postmortem detection of early myocardial damage. Forensic Sci Int 160: 11-16, 2006.